Supplementary Figure S4. Evaluation of disease state in vehicle control treated animals by IHC. from In Vitro and In Vivo Efficacy of a Novel CD33-Targeted Thorium-227 Conjugate for the Treatment of Acute Myeloid Leukemia

MLA

Alan S. Cuthbertson, et al. Supplementary Figure S4. Evaluation of Disease State in Vehicle Control Treated Animals by IHC. from In Vitro and In Vivo Efficacy of a Novel CD33-Targeted Thorium-227 Conjugate for the Treatment of Acute Myeloid Leukemia. Apr. 2023. EBSCOhost, https://doi.org/10.1158/1535-7163.22504036.

APA

Alan S. Cuthbertson, Olav B. Ryan, Roger M. Bjerke, Jenny Karlsson, Kristine Sponheim, Adam O. Shea, Ellen Wang, Katrine Wickstroem, & Urs B. Hagemann. (2023). Supplementary Figure S4. Evaluation of disease state in vehicle control treated animals by IHC. from In Vitro and In Vivo Efficacy of a Novel CD33-Targeted Thorium-227 Conjugate for the Treatment of Acute Myeloid Leukemia. https://doi.org/10.1158/1535-7163.22504036

Chicago

Alan S. Cuthbertson, Olav B. Ryan, Roger M. Bjerke, Jenny Karlsson, Kristine Sponheim, Adam O. Shea, Ellen Wang, Katrine Wickstroem, and Urs B. Hagemann. 2023. “Supplementary Figure S4. Evaluation of Disease State in Vehicle Control Treated Animals by IHC. from In Vitro and In Vivo Efficacy of a Novel CD33-Targeted Thorium-227 Conjugate for the Treatment of Acute Myeloid Leukemia,” April. doi:10.1158/1535-7163.22504036.